ArticleBlood2018
Venetoclax after idelalisib: relevant progress for CLL.
Francesc Bosch et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBlood2018
Francesc Bosch et al.PubMed ↗Publisher ↗
No numbers read from the abstract.